tiprankstipranks
Advertisement
Advertisement

AURA Stock Latest News

Aura Biosciences price target lowered to $17 from $26 at Leerink
The FlyAura Biosciences price target lowered to $17 from $26 at Leerink
10d ago
AURA
Aura Biosciences reports Q1 results, appoints new CEO
PremiumCompany Announcements
Aura Biosciences reports Q1 results, appoints new CEO
11d ago
8K
AURA
Aura Biosciences Completes Major Underwritten Equity Financing
PremiumCompany Announcements
Aura Biosciences Completes Major Underwritten Equity Financing
17d ago
8K
AURA
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
PremiumCompany Announcements
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
18d ago
8K
AURA
Aura Biosciences $260M Spot Secondary priced at $6.00
PremiumThe Fly
Aura Biosciences $260M Spot Secondary priced at $6.00
18d ago
AURA
Aura Biosciences Advances CoMpass Phase 3 Trial Progress
PremiumCompany AnnouncementsAura Biosciences Advances CoMpass Phase 3 Trial Progress
18d ago
8K
AURA
Aura Biosciences announces common stock, pre-funded warrant offering
Premium
The Fly
Aura Biosciences announces common stock, pre-funded warrant offering
18d ago
AURA
Aura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO
Premium
The Fly
Aura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO
18d ago
AURA
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
PremiumThe Fly
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
1M ago
AURA
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
PremiumRatings
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
2M ago
AURA
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
PremiumCompany Announcements
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
2M ago
8K
AURA
Is AURA a Buy, Before Earnings?
PremiumPre-Earnings
Is AURA a Buy, Before Earnings?
2M ago
AURA
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
PremiumCompany AnnouncementsAura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
3M ago
AURA
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
Premium
Ratings
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
6M ago
AURA
Aura Biosciences re-initiated with an Outperform at Evercore ISI
Premium
The Fly
Aura Biosciences re-initiated with an Outperform at Evercore ISI
6M ago
AURA
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
PremiumRatings
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
6M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Aura Biosciences Reports Q3 2025 Financial Results
6M ago
AURA
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
PremiumRatings
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
6M ago
AURA
Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion
PremiumRatings
Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion
6M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsAura Biosciences Reports Q3 2025 Financial Results
6M ago
8K
AURA
Aura Biosciences reports Q3 EPS (40c), consensus (47c)
Premium
The Fly
Aura Biosciences reports Q3 EPS (40c), consensus (47c)
6M ago
AURA
Aura Biosciences announces cash to fund operations into 1H of 2027
Premium
The Fly
Aura Biosciences announces cash to fund operations into 1H of 2027
6M ago
AURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >